Company news

Nexsen Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Proposed issue of securities - NXN

November 20, 2026

Nexsen Appointments to Advisory Board

November 15, 2026

A$1.2 million R&D Tax Incentive refund received

November 12, 2026

Results of Meeting

November 9, 2026

Nexsen advances kidney diagnostics program

November 5, 2026

Co Secretary Appoint/Resign and Change of Registered Address

November 2, 2026

ISO 13485 Certification brings StrepSure closer to market

November 1, 2026

Quarterly Report - Q1 FY27

October 27, 2026

Quarterly Report - Q1 FY27

October 27, 2026

Notice of AGM and Meeting Materials

October 7, 2026

Professor Shekhar Kumta appointed Executive Director

September 30, 2026

Reinstatement to Quotation

September 24, 2026

Proposed FlashDx joint venture builds on CE-marked GBS test

September 24, 2026

Suspension from Quotation

September 23, 2026

Clear pathway defined to optimise StrepSure

September 23, 2026

Trading Halt

September 21, 2026

Director Interest Notices re Performance Rights

September 10, 2026

Notification regarding unquoted securities - NXN

September 10, 2026

Notification regarding unquoted securities - NXN

September 10, 2026

Annual Report - FY 2026

August 30, 2026

Corporate Governance Statement and Appendix 4G

August 30, 2026

Quarterly Report - Q4 FY26

July 28, 2026

$1.5m non-dilutive ARC funding for manufacturing

June 24, 2026

Nexsen secures first hospital partner in Asia

May 12, 2026

Nexsen and Universiti Malaya launch joint facility

May 3, 2026

Quarterly Report - Q3 FY26

April 27, 2026

QMS milestone achieved

April 6, 2026

HK$6 million grant awarded to advance Asia-Pacific execution

March 30, 2026

Nexsen accelerates global rollout for StrepSure

March 25, 2026

FDA feedback derisks US approval pathway for StrepSure

March 22, 2026

Half Yearly Report and Accounts

February 26, 2026

Quarterly Report - Q2 FY26

January 29, 2026

$500k govt grant expands GBS project to neonates

January 26, 2026

Investor Presentation

December 7, 2025

Nexsen Appoints Global Clinical Leader to the Board

December 2, 2025

Quarterly Report - Q1 FY26

October 31, 2025

Nexsen launches clinical trial for GBS Rapid Sensor

October 20, 2025

Decks